Botox Developer Regrets Missed Opportunity to Mint Money
Monday, March 12, 2012
Botox developer Alan Scott, who sold the rights for the wrinkle-smoothing drug to a US company for just $4.5 million, says he regrets the move.
Botox has become a front-line weapon in cosmetic medicine for erasing wrinkles — while therapeutic applications of the drug are being used to help a wide variety of disorders from swallowing problems to muscle spasms.
“If I knew (how big it would become), I would have never given it to the drug company Allergan in 1991,” Dr Alan Scott told the Times of India in an interview published on Monday.